Page last updated: 2024-08-26

cyproterone acetate, ethinyl estradiol drug combination and Cancer of Liver

cyproterone acetate, ethinyl estradiol drug combination has been researched along with Cancer of Liver in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Regidor, M; Regidor, PA; Schindler, EM; Speer, K1

Trials

1 trial(s) available for cyproterone acetate, ethinyl estradiol drug combination and Cancer of Liver

ArticleYear
[Long-term side-effects following cyproterone acetate containing therapy in gynecology].
    Zentralblatt fur Gynakologie, 2000, Volume: 122, Issue:5

    Topics: Adult; Androgen Antagonists; Carcinoma, Hepatocellular; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Follow-Up Studies; Hirsutism; Humans; Liver Neoplasms; Risk Factors

2000